OWOlaf Wendler

Olaf Wendler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Olaf Wendler has a total of 193 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Gender-based outcomes following surgical aortic valve replacement: a multicentre propensity score matching analysis

    by Ruggero De Paulis, Farhad Bakhtiary, Ali El-Sayed Ahmad, Martin Andreas, Rüdiger Autschbach, Peter Benedikt, Konrad Binder, Nikolaos Bonaros, Michael Borger, Thierry Bourguignon, et al.

    OBJECTIVES: This study investigated the gnder-based difference in three-year clinical outcomes, left ventricular (LV) regression, and quality-of-life (QoL) following surgical aortic valve replacement (SAVR) by propensity score matching (PSM). METHODS: A prospective multicentre study on combined data from two prospective registries, INDURE and IMPACT, resulted in 993 patients (735 males and 258 females). PSM yielded 689 patients: 442 males and 247 females undergoing first-time SAVR using Edwards INSPIRIS RESILIA. RESULTS: In the PSM cohort, females had lower body mass index (median 27.9 vs 28.6 kg/m2; P = 0.004), higher European System for Cardiac Operative Risk Evaluation (EuroSCORE) II (2.4 ± 3.0 % vs 1.8 ± 1.9 %; P < 0.001), Society of Thoracic Surgeons (STS) score (1.8 ± 1.7 % vs 1.3 ± 2.0 %; P < 0.001) and were most often in New York Heart Association class III/IV (45.7 % vs 37.6 %; P < 0.021), angina CCS class III/IV (6.1 % vs 2.9 %; P < 0.001) than males. Post-SAVR clinical outcomes up to three years were similar between both genders. Significant differences existed for LV regression after surgery between genders at up to three years (P < 0.001) with better haemodynamic performance. Hypertension slowed the LV mass regression, mildly affecting LV restoration in females for up to three years. In both genders, New York Heart Association status was restored within one year (P < 0.001) and maintained for up to three years (P < 0.001). At three years, QoL significantly improved. CONCLUSIONS: Despite females presenting with a significantly higher surgical risk profile, three-year outcomes following SAVR were comparable between genders with significant improvement in functional status. However, the degree of QoL improvement differed between genders. Clinical trial registration number: ClinicalTrials.gov NCT04053088/-NCT03666741


  • Open Access

    Racial and ethnic disparities in aortic stenosis within a universal healthcare system characterized by natural language processing for targeted intervention

    by Dhruva Biswas, Jack Wu, Sam Brown, Apurva Bharucha, Natalie Fairhurst, George Kaye, Kate Jones, Freya Parker Copeland, Bethan O’dOnnell, Daniel Kyle, et al.

    Aims: Aortic stenosis (AS) is a condition marked by high morbidity and mortality in severe, symptomatic cases without intervention via transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement (SAVR). Racial and ethnic disparities in access to these treatments have been documented, particularly in North America, where socioeconomic factors such as health insurance confound analyses. This study evaluates disparities in AS management across racial and ethnic groups, accounting for socioeconomic deprivation, using an artificial intelligence (AI) framework. Methods and results: We conducted a retrospective cohort study using a natural language processing pipeline to analyse both structured and unstructured data from > 1 million patients at a London hospital. Key variables included age, sex, self-reported race and ethnicity, AS severity, and socioeconomic status. The primary outcomes were rates of valvular intervention and all-cause mortality. Among 6967 patients with AS, Black patients were younger, more symptomatic, and more comorbid than White patients. Black patients with objective evidence of AS on echocardiography were less likely to receive a clinical diagnosis than White patients. In severe AS, TAVI and SAVR procedures were performed at lower rates among Black patients than among White patients, with a longer time to SAVR. In multivariate analysis of severe AS, controlling for socioeconomic status, Black patients experienced higher mortality (hazard ratio = 1.42, 95% confidence interval = 1.05–1.92, P = 0.02). Conclusion: An AI framework characterizes racial and ethnic disparities in AS management, which persist in a universal healthcare system, highlighting targets for future healthcare interventions.


  • Open Access

    Porcelain Aorta and Radiation-Induced Mitral Annular Calcification Are Not Contraindications to Surgery

    by Joseph Okafor, Helen Thomson, Carole Ridge, Guy Lloyd, Gentjan Jakaj, Bernard Prendergast, Olaf Wendler


  • Open Access

    Sex-related differences among patients undergoing surgical aortic valve replacement—a propensity score matched study

    by Andreas Zierer, Ruggero De Paulis, Farhad Bakhtiary, Ali El-Sayed Ahmad, Martin Andreas, Rüdiger Autschbach, Peter Benedikt, Konrad Binder, Nikolaos Bonaros, Michael Borger, et al.

    We investigated the sex-related difference in characteristics and 2-year outcomes after surgical aortic valve replacement (SAVR) by propensity-score matching (PSM). Data from 2 prospective registries, the INSPIRIS RESILIA Durability Registry (INDURE) and IMPACT, were merged, resulting in a total of 933 patients: 735 males and 253 females undergoing first-time SAVR. The PSM was performed to assess the impact of sex on the SAVR outcomes, yielding 433 males and 243 females with comparable baseline characteristics. Females had a lower body mass index (median 27.1 vs 28.0 kg/m2; P = 0.008), fewer bicuspid valves (52% vs 59%; P = 0.036), higher EuroSCORE II (mean 2.3 vs 1.8%; P < 0.001) and Society of Thoracic Surgeons score (mean 1.6 vs 0.9%; P < 0.001), were more often in New York Heart Association functional class III/IV (47% vs 30%; P < 0.001) and angina Canadian Cardiovascular Society III/IV (8.2% vs 4.4%; P < 0.001), but had a lower rate of myocardial infarction (1.9% vs 5.2%; P = 0.028) compared to males. These differences vanished after PSM, except for the EuroSCORE II and Society of Thoracic Surgeons scores, which were still significantly higher in females. Furthermore, females required smaller valves (median diameter 23.0 vs 25.0 mm, P < 0.001). There were no differences in the length of hospital stay (median 8 days) or intensive care unit stay (median 24 vs 25 hours) between the 2 sexes. At 2 years, post-SAVR outcomes were comparable between males and females, even after PSM. Despite females presenting with a significantly higher surgical risk profile, 2-year outcomes following SAVR were comparable between males and females.


  • Guidelines for Infective Endocarditis

    by Ross Roberts-Thomson, Olaf Wendler, Bernard D. Prendergast

  • Open Access

    Durability of bioprosthetic aortic valve replacement in patients under the age of 60 years — 1-year follow-up from the prospective INDURE registry

    by Bart Meuris, Jean-Christian Roussel, Michael A Borger, Matthias Siepe, Pierluigi Stefano, Günther Laufer, Thierry Langanay, Alexis Theron, Martin Grabenwöger, Konrad Binder, et al.

    We report 1-year safety and clinical outcomes in patients 2. The 1-year data from the INSPIRIS RESILIA valve demonstrate good safety and excellent haemodynamic performance as well as an early QoL improvement. clinicaltrials.gov: NCT03666741.


  • CARDIAC MITOCHONDRIAL INJURY DURING ON-PUMP CARDIAC SURGERY PRINCIPALLY INVOLVES COMPLEX I OF THE ELECTRON TRANSPORT CHAIN AND RELATES TO POSTOPERATIVE INOTROPIC REQUIREMENTS

    by Huda Abu-Own, Kavya Pillai, Roman Roy, Azhar Hussain, Gentjan Jakaj, Sameh Mohamed, Ashok Narayana, Habib Khan, Ranjit Deshpande, Donald Whitaker, et al.

  • BLUNTED TEMPORAL IMPROVEMENTS IN SURVIVAL IN PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION UNDERGOING CARDIAC SURGERY

    by Huda Abu-Own, Gentjan Jakaj, Roman Roy, Azhar Hussain, Sameh Mohamed, Kavya Pillai, Pia Thapliyal, Ashok Narayana, Habib Khan, Donald Whitaker, et al.

  • Open Access

    Disruptive technologies in mitral modelling—a riot of innovation

    by Apurva H Bharucha, Mehdi Eskandari, Olaf Wendler, Max Baghai

    The anatomical and functional complexities of mitral valve pathologies render clinical decision-making and intervention challenging particularly in emergent settings such as acute papillary muscle (PM) rupture. Although rare since the advent of percutaneous coronary intervention, PM rupture carries a dismal prognosis, with a recent multicentre study published in this journal revealing an in-hospital mortality of 24.9% in those undergoing surgical intervention [ 1]. Given the rarity of PM rupture, the literature comprises of small retrospective studies producing a paucity of evidence to comprehensively guide patient selection, timing of intervention and the use of bridging strategies Moreover, the limited evidence base precludes a comprehensive understanding of the anatomical, haemodynamic and physiological mechanisms underpinning outcomes in such patients. In this context, Marin-Cuartas et al. [ 2] have developed the an ex vivo platform comprising of porcine valves mounted within a left heart simulator to model the haemodynamic effects of acute PM rupture simulated by incrementally cutting chordae to a given PM head. Ex vivo mitral models are fundamental to mitral research and this diligently designed study provides an apt reminder of the strengths of this modelling modality in enhancing our understanding of mitral disease processes and spawning research hypotheses especially in areas where the evidence base is limited such as PM rupture. This commendable hypothesis generating work suggests the presence of sub-phenotypic groups within those with PM rupture, the characterization of which could allow for more precise and efficacious interventional strategies and sets the stage for further study in this challenging research area. Given the acuity and rarity of PM rupture, such information would be difficult to derive from clinical studies.


  • Abstract 14169: Implications of Elevated Troponin on Time-to-Surgery in Non-ST Elevation Myocardial Infarction (NIHR Health Informatics Collaborative: Trop-CABG Study)

    by Shubhra Sinha, Umberto Benedetto, Abdulrahim Mulla, Ben Glampson, Vasileios F. Panoulas, Sanjay Gautama, Jim Davies, Dimitri Papadimitriou, Kerrie Woods, Paul Elliott, et al.

    Background: The optimal timing of coronary artery bypass grafting(CABG) in patients with non-ST elevation myocardial infarction (NSTEMI) and the utility of pre-operative troponin levels in decision-making remains unclear. We investigated (a)the association between peak pre-operative troponin and survival post-CABG in a large cohort of NSTEMI patients and (b)the interaction between troponin and time-to-surgery. Methods: Our cohort consisted of 1746 NSTEMI patients(mean age 69±11 years, 21% female) with recorded troponins that had CABG at five United Kingdom centers between 2010 and 2017. Time-segmented Cox regression was used to investigate the interaction of peak troponin and time-to-surgery on early(within 30 days) and late(beyond 30 days) survival. Results: Average interval from peak troponin to surgery was 9±15 days, with 1466(84.0%) patients having CABG during the same admission. Sixty patients died within 30-days and another 211 died after a mean follow-up of 4±2years(30-day survival 0.97±0.004 and 5-year survival 0.83±0.01). Peak troponin was a strong predictor of early survival(adjusted P=0.002) with a significant interaction with time-to-surgery(P interaction=0.007). For peak troponin levels Conclusions: Peak troponin in NSTEMI patients undergoing CABG was a significant predictor of early mortality, strongly influenced the time-to-surgery and may prove to be a clinically useful biomarker in the management of these patients.